nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—PGR—migraine	0.369	0.613	CbGaD
Medroxyprogesterone Acetate—ESR1—migraine	0.233	0.387	CbGaD
Medroxyprogesterone Acetate—CYP2C8—Amitriptyline—migraine	0.0303	0.154	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Valproic Acid—migraine	0.0276	0.14	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Verapamil—migraine	0.0241	0.122	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Amitriptyline—migraine	0.0211	0.107	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Valproic Acid—migraine	0.0193	0.0979	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Verapamil—migraine	0.0168	0.0853	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Propranolol—migraine	0.0142	0.0722	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Amitriptyline—migraine	0.0123	0.0625	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Valproic Acid—migraine	0.0112	0.0569	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Topiramate—migraine	0.0101	0.0514	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Verapamil—migraine	0.00976	0.0496	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—head—migraine	0.00106	0.056	CbGeAlD
Medroxyprogesterone Acetate—Dydrogesterone—PGR—migraine	0.00105	0.226	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—nervous system—migraine	0.001	0.0531	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—migraine	0.001	0.053	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—migraine	0.000967	0.0512	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—trigeminal ganglion—migraine	0.000914	0.0484	CbGeAlD
Medroxyprogesterone Acetate—Ethynodiol—PGR—migraine	0.000862	0.186	CrCbGaD
Medroxyprogesterone Acetate—SHBG—neck—migraine	0.000796	0.0421	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—migraine	0.000784	0.0415	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—migraine	0.000768	0.0406	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nerve—migraine	0.000736	0.039	CbGeAlD
Medroxyprogesterone Acetate—Megestrol acetate—PGR—migraine	0.00063	0.136	CrCbGaD
Medroxyprogesterone Acetate—SHBG—brainstem—migraine	0.000608	0.0322	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—Retinoid metabolism and transport—LRP1—migraine	0.000589	0.0566	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—neck—migraine	0.000561	0.0297	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—PGR—migraine	0.00055	0.118	CrCbGaD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—migraine	0.000544	0.117	CrCbGaD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—migraine	0.000496	0.0263	CbGeAlD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—FOS—migraine	0.000483	0.0464	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—cardiovascular system—migraine	0.000447	0.0237	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brainstem—migraine	0.000429	0.0227	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—neck—migraine	0.000414	0.0219	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—migraine	0.000399	0.0211	CbGeAlD
Medroxyprogesterone Acetate—Spironolactone—PGR—migraine	0.000392	0.0844	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—trigeminal ganglion—migraine	0.000357	0.0189	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiovascular system—migraine	0.000356	0.0188	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—migraine	0.00035	0.0185	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—migraine	0.000324	0.0171	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—migraine	0.000316	0.0167	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—migraine	0.000307	0.0162	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—migraine	0.000303	0.016	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—LRP1—migraine	0.000301	0.0289	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—cerebellum—migraine	0.0003	0.0159	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.000299	0.0288	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Circadian Clock—MEF2D—migraine	0.000291	0.028	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—nervous system—migraine	0.000287	0.0152	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—migraine	0.000276	0.0146	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—migraine	0.00027	0.0143	CbGeAlD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—migraine	0.00027	0.0582	CrCbGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—PGR—migraine	0.000264	0.0254	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—migraine	0.000258	0.0136	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—migraine	0.000256	0.0135	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—migraine	0.000244	0.0129	CbGeAlD
Medroxyprogesterone Acetate—AR—head—migraine	0.000241	0.0128	CbGeAlD
Medroxyprogesterone Acetate—ESR1—head—migraine	0.000237	0.0125	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—migraine	0.000229	0.0121	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—migraine	0.000225	0.0119	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—migraine	0.00022	0.0116	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—migraine	0.000219	0.0116	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—migraine	0.000216	0.0114	CbGeAlD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000214	0.0206	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—PGR—migraine	0.000212	0.0457	CrCbGaD
Medroxyprogesterone Acetate—ESR1—cerebellum—migraine	0.000211	0.0112	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—FOS—migraine	0.000211	0.0203	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—PGR—migraine	0.000209	0.0201	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptors—PGR—migraine	0.000203	0.0196	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—PGR—migraine	0.0002	0.0193	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear signaling by ERBB4—PGR—migraine	0.000199	0.0192	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear Receptors—ESR1—migraine	0.000185	0.0178	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—HTR3A—migraine	0.000182	0.0175	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear signaling by ERBB4—ESR1—migraine	0.000181	0.0174	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—brain—migraine	0.000175	0.00925	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—migraine	0.000175	0.00924	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—migraine	0.000172	0.00908	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—migraine	0.000166	0.00876	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000162	0.0156	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—PGR—migraine	0.000161	0.0155	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—central nervous system—migraine	0.000159	0.00844	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—migraine	0.000158	0.0152	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—cerebellum—migraine	0.000156	0.00824	CbGeAlD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—FOS—migraine	0.000149	0.0144	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—MEF2D—migraine	0.000146	0.0141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Estrogen signaling pathway—FOS—migraine	0.000146	0.0141	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000146	0.0141	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—brain—migraine	0.000141	0.00748	CbGeAlD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—ESR1—migraine	0.000141	0.0136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Cellular roles of Anthrax toxin—TNF—migraine	0.000139	0.0133	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HTR3A—migraine	0.000138	0.0133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—PGR—migraine	0.000134	0.0129	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—ESR1—migraine	0.000134	0.0288	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—brain—migraine	0.000127	0.0067	CbGeAlD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—ESR1—migraine	0.000125	0.0121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—nervous system—migraine	0.000125	0.00663	CbGeAlD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—ESR1—migraine	0.000122	0.0117	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—migraine	0.000121	0.00638	CbGeAlD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—FOS—migraine	0.000113	0.0109	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000111	0.0107	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—ESR1—migraine	0.000107	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—migraine	0.000107	0.0103	CbGpPWpGaD
Medroxyprogesterone Acetate—Arthralgia—Valproic Acid—migraine	0.000104	0.00062	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Valproic Acid—migraine	0.000104	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Verapamil—migraine	0.000104	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000104	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Topiramate—migraine	0.000103	0.000613	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Gabapentin—migraine	0.000103	0.000613	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Valproic Acid—migraine	0.000103	0.000613	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Topiramate—migraine	0.000103	0.00061	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Gabapentin—migraine	0.000102	0.000608	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Valproic Acid—migraine	0.000102	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Gabapentin—migraine	0.000102	0.000604	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Gabapentin—migraine	0.000102	0.000604	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Propranolol—migraine	0.000101	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Verapamil—migraine	0.000101	0.000602	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Valproic Acid—migraine	0.000101	0.000599	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Gabapentin—migraine	0.0001	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Valproic Acid—migraine	9.99e-05	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Valproic Acid—migraine	9.99e-05	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Topiramate—migraine	9.99e-05	0.000594	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Verapamil—migraine	9.97e-05	0.000593	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Gabapentin—migraine	9.96e-05	0.000593	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Timolol—migraine	9.96e-05	0.000593	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Gabapentin—migraine	9.94e-05	0.000591	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Valproic Acid—migraine	9.93e-05	0.000591	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Topiramate—migraine	9.86e-05	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Gabapentin—migraine	9.86e-05	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Gabapentin—migraine	9.82e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Topiramate—migraine	9.81e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Topiramate—migraine	9.81e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Valproic Acid—migraine	9.8e-05	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Timolol—migraine	9.79e-05	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Valproic Acid—migraine	9.79e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Timolol—migraine	9.78e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Gabapentin—migraine	9.76e-05	0.000581	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Valproic Acid—migraine	9.75e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Propranolol—migraine	9.74e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Topiramate—migraine	9.74e-05	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Valproic Acid—migraine	9.71e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Topiramate—migraine	9.69e-05	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Topiramate—migraine	9.67e-05	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Valproic Acid—migraine	9.66e-05	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Propranolol—migraine	9.66e-05	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Propranolol—migraine	9.65e-05	0.000574	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Verapamil—migraine	9.64e-05	0.000574	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Topiramate—migraine	9.64e-05	0.000574	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Timolol—migraine	9.63e-05	0.000573	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Topiramate—migraine	9.62e-05	0.000572	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Timolol—migraine	9.58e-05	0.00057	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Valproic Acid—migraine	9.53e-05	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Gabapentin—migraine	9.51e-05	0.000566	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Topiramate—migraine	9.46e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Gabapentin—migraine	9.42e-05	0.00056	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Gabapentin—migraine	9.38e-05	0.000558	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Valproic Acid—migraine	9.34e-05	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Gabapentin—migraine	9.33e-05	0.000555	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Verapamil—migraine	9.32e-05	0.000554	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Timolol—migraine	9.28e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Timolol—migraine	9.28e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Timolol—migraine	9.28e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Topiramate—migraine	9.28e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Gabapentin—migraine	9.28e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Timolol—migraine	9.25e-05	0.00055	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	9.22e-05	0.000548	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Timolol—migraine	9.17e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Topiramate—migraine	9.17e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Gabapentin—migraine	9.16e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Topiramate—migraine	9.15e-05	0.000544	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Gabapentin—migraine	9.12e-05	0.000543	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Valproic Acid—migraine	9.11e-05	0.000542	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Topiramate—migraine	9.11e-05	0.000542	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Gabapentin—migraine	9.1e-05	0.000542	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Propranolol—migraine	9.1e-05	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Timolol—migraine	9.08e-05	0.00054	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Valproic Acid—migraine	9.04e-05	0.000538	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—FOS—migraine	9.03e-05	0.00869	CbGpPWpGaD
Medroxyprogesterone Acetate—Paraesthesia—Valproic Acid—migraine	8.97e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Gabapentin—migraine	8.97e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Timolol—migraine	8.97e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Verapamil—migraine	8.96e-05	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Gabapentin—migraine	8.92e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Valproic Acid—migraine	8.91e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Topiramate—migraine	8.9e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Timolol—migraine	8.9e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Timolol—migraine	8.9e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Verapamil—migraine	8.89e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Valproic Acid—migraine	8.89e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Verapamil—migraine	8.88e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Topiramate—migraine	8.86e-05	0.000527	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Topiramate—migraine	8.84e-05	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Timolol—migraine	8.84e-05	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Verapamil—migraine	8.83e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Topiramate—migraine	8.8e-05	0.000524	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Valproic Acid—migraine	8.8e-05	0.000523	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Gabapentin—migraine	8.8e-05	0.000523	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Timolol—migraine	8.75e-05	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Timolol—migraine	8.73e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—FOXA1 transcription factor network—FOS—migraine	8.7e-05	0.00837	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Valproic Acid—migraine	8.69e-05	0.000517	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Topiramate—migraine	8.67e-05	0.000516	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—HTR1A—migraine	8.66e-05	0.00833	CbGpPWpGaD
Medroxyprogesterone Acetate—Chest pain—Gabapentin—migraine	8.64e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Gabapentin—migraine	8.64e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Gabapentin—migraine	8.64e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Timolol—migraine	8.64e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Valproic Acid—migraine	8.63e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Valproic Acid—migraine	8.62e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Gabapentin—migraine	8.61e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Timolol—migraine	8.6e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Topiramate—migraine	8.6e-05	0.000511	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	8.58e-05	0.000511	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Valproic Acid—migraine	8.55e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Topiramate—migraine	8.54e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Topiramate—migraine	8.54e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Gabapentin—migraine	8.54e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TAC1—migraine	8.52e-05	0.0082	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Timolol—migraine	8.48e-05	0.000504	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Gabapentin—migraine	8.45e-05	0.000503	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—migraine	8.45e-05	0.00813	CbGpPWpGaD
Medroxyprogesterone Acetate—Flatulence—Topiramate—migraine	8.42e-05	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Topiramate—migraine	8.38e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Verapamil—migraine	8.37e-05	0.000498	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Topiramate—migraine	8.36e-05	0.000498	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—SLC6A4—migraine	8.36e-05	0.00804	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Gabapentin—migraine	8.35e-05	0.000497	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Timolol—migraine	8.31e-05	0.000495	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Topiramate—migraine	8.3e-05	0.000493	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Gabapentin—migraine	8.29e-05	0.000493	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Gabapentin—migraine	8.29e-05	0.000493	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Topiramate—migraine	8.26e-05	0.000491	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CACNA1A—migraine	8.25e-05	0.00794	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Valproic Acid—migraine	8.24e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Gabapentin—migraine	8.23e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Topiramate—migraine	8.21e-05	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Valproic Acid—migraine	8.17e-05	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Gabapentin—migraine	8.15e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Gabapentin—migraine	8.13e-05	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Gabapentin—migraine	8.11e-05	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Timolol—migraine	8.11e-05	0.000482	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Gabapentin—migraine	8.09e-05	0.000481	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Gabapentin—migraine	8.05e-05	0.000479	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Timolol—migraine	8.05e-05	0.000479	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—migraine	8.02e-05	0.00771	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Gabapentin—migraine	8.01e-05	0.000476	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Topiramate—migraine	8e-05	0.000476	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Timolol—migraine	7.99e-05	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Valproic Acid—migraine	7.94e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Timolol—migraine	7.93e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Topiramate—migraine	7.92e-05	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Timolol—migraine	7.91e-05	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Valproic Acid—migraine	7.9e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Valproic Acid—migraine	7.9e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Gabapentin—migraine	7.9e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Topiramate—migraine	7.89e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Topiramate—migraine	7.85e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Timolol—migraine	7.83e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Gabapentin—migraine	7.74e-05	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Timolol—migraine	7.73e-05	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Topiramate—migraine	7.7e-05	0.000458	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	7.69e-05	0.0074	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Timolol—migraine	7.68e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Topiramate—migraine	7.67e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Timolol—migraine	7.67e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Topiramate—migraine	7.66e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Gabapentin—migraine	7.55e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Topiramate—migraine	7.55e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Topiramate—migraine	7.51e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Gabapentin—migraine	7.49e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Gabapentin—migraine	7.44e-05	0.000443	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Topiramate—migraine	7.4e-05	0.00044	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Gabapentin—migraine	7.39e-05	0.000439	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Gabapentin—migraine	7.37e-05	0.000438	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Valproic Acid—migraine	7.36e-05	0.000438	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Timolol—migraine	7.33e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Gabapentin—migraine	7.29e-05	0.000434	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Timolol—migraine	7.28e-05	0.000433	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Topiramate—migraine	7.27e-05	0.000433	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Topiramate—migraine	7.27e-05	0.000433	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Topiramate—migraine	7.27e-05	0.000433	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Topiramate—migraine	7.25e-05	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.22e-05	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Gabapentin—migraine	7.2e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Topiramate—migraine	7.18e-05	0.000427	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Valproic Acid—migraine	7.17e-05	0.000427	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Gabapentin—migraine	7.15e-05	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Gabapentin—migraine	7.14e-05	0.000425	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Topiramate—migraine	7.11e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Gabapentin—migraine	7.09e-05	0.000421	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Valproic Acid—migraine	7.07e-05	0.000421	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Timolol—migraine	7.07e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Timolol—migraine	7.03e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Timolol—migraine	7.03e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Topiramate—migraine	7.03e-05	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Topiramate—migraine	6.97e-05	0.000415	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	6.93e-05	0.00667	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Topiramate—migraine	6.93e-05	0.000412	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—FOS—migraine	6.88e-05	0.00662	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Topiramate—migraine	6.86e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Valproic Acid—migraine	6.84e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Topiramate—migraine	6.84e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Gabapentin—migraine	6.83e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Topiramate—migraine	6.83e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Topiramate—migraine	6.8e-05	0.000405	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Gabapentin—migraine	6.78e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Topiramate—migraine	6.77e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Topiramate—migraine	6.74e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PGR—migraine	6.7e-05	0.00645	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Topiramate—migraine	6.64e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Valproic Acid—migraine	6.61e-05	0.000393	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Gabapentin—migraine	6.58e-05	0.000392	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HTR1A—migraine	6.57e-05	0.00632	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—ESR1—migraine	6.56e-05	0.00631	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Timolol—migraine	6.56e-05	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Gabapentin—migraine	6.55e-05	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Gabapentin—migraine	6.55e-05	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Topiramate—migraine	6.51e-05	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TGFBR2—migraine	6.47e-05	0.00623	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TAC1—migraine	6.47e-05	0.00622	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Timolol—migraine	6.38e-05	0.00038	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Valproic Acid—migraine	6.35e-05	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Topiramate—migraine	6.35e-05	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—migraine	6.34e-05	0.0061	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Topiramate—migraine	6.3e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Valproic Acid—migraine	6.3e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Valproic Acid—migraine	6.3e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Timolol—migraine	6.29e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Valproic Acid—migraine	6.26e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Topiramate—migraine	6.26e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Topiramate—migraine	6.21e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Topiramate—migraine	6.2e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—FOS—migraine	6.14e-05	0.00591	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Topiramate—migraine	6.14e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Gabapentin—migraine	6.1e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—ESR1—migraine	6.1e-05	0.00587	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Timolol—migraine	6.09e-05	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—BDNF—migraine	6.07e-05	0.00584	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Topiramate—migraine	6.06e-05	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Topiramate—migraine	6.02e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Topiramate—migraine	6.01e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—FOS—migraine	6e-05	0.00577	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Topiramate—migraine	5.96e-05	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Gabapentin—migraine	5.94e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Valproic Acid—migraine	5.94e-05	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—FOS—migraine	5.91e-05	0.00568	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Timolol—migraine	5.88e-05	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Gabapentin—migraine	5.86e-05	0.000349	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	5.83e-05	0.00561	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Topiramate—migraine	5.74e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Topiramate—migraine	5.7e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Gabapentin—migraine	5.67e-05	0.000337	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Timolol—migraine	5.66e-05	0.000337	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Timolol—migraine	5.61e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Timolol—migraine	5.6e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Timolol—migraine	5.57e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Topiramate—migraine	5.54e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Topiramate—migraine	5.51e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Topiramate—migraine	5.51e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Gabapentin—migraine	5.48e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	5.34e-05	0.00514	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Timolol—migraine	5.29e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Gabapentin—migraine	5.27e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	5.26e-05	0.00506	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Gabapentin—migraine	5.22e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Gabapentin—migraine	5.22e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—FOS—migraine	5.21e-05	0.00501	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Gabapentin—migraine	5.19e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NOTCH4—migraine	5.17e-05	0.00497	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.16e-05	0.00497	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Topiramate—migraine	5.14e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—HTR2A—migraine	5.13e-05	0.00493	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Topiramate—migraine	5e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TGFBR2—migraine	4.99e-05	0.0048	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Topiramate—migraine	4.93e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Gabapentin—migraine	4.92e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Topiramate—migraine	4.77e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—ESR1—migraine	4.67e-05	0.00449	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Topiramate—migraine	4.61e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—migraine	4.61e-05	0.00443	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—migraine	4.51e-05	0.00434	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RAMP1—migraine	4.5e-05	0.00432	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CALCRL—migraine	4.5e-05	0.00432	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Topiramate—migraine	4.43e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Topiramate—migraine	4.4e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NOTCH3—migraine	4.39e-05	0.00423	CbGpPWpGaD
Medroxyprogesterone Acetate—Dermatitis—Topiramate—migraine	4.39e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Topiramate—migraine	4.37e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Topiramate—migraine	4.14e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CACNA1A—migraine	4.07e-05	0.00392	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.98e-05	0.00383	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NOTCH4—migraine	3.94e-05	0.00379	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—migraine	3.89e-05	0.00374	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.87e-05	0.00372	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—LRP1—migraine	3.82e-05	0.00367	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PGR—migraine	3.6e-05	0.00346	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALCRL—migraine	3.55e-05	0.00341	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RAMP1—migraine	3.55e-05	0.00341	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NOTCH3—migraine	3.35e-05	0.00322	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR1D—migraine	3.27e-05	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2B—migraine	3.04e-05	0.00292	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NOTCH4—migraine	3.03e-05	0.00292	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NOTCH4—migraine	2.99e-05	0.00287	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PGR—migraine	2.77e-05	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PGR—migraine	2.73e-05	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—MTHFR—migraine	2.73e-05	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LRP1—migraine	2.67e-05	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NOTCH3—migraine	2.58e-05	0.00248	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR1D—migraine	2.58e-05	0.00248	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NOTCH3—migraine	2.54e-05	0.00244	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—ESR1—migraine	2.52e-05	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH4—migraine	2.49e-05	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CALCA—migraine	2.46e-05	0.00237	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2B—migraine	2.4e-05	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—migraine	2.21e-05	0.00212	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH3—migraine	2.12e-05	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LRP1—migraine	2.11e-05	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAMP1—migraine	2.08e-05	0.002	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCRL—migraine	2.08e-05	0.002	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH4—migraine	2.05e-05	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFBR2—migraine	1.98e-05	0.00191	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR1B—migraine	1.98e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—migraine	1.94e-05	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—ESR1—migraine	1.92e-05	0.00185	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR1A—migraine	1.9e-05	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH4—migraine	1.9e-05	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PGR—migraine	1.88e-05	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NPS—migraine	1.88e-05	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TAC1—migraine	1.88e-05	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.88e-05	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2C—migraine	1.84e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EDNRA—migraine	1.79e-05	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH3—migraine	1.74e-05	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PGR—migraine	1.73e-05	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CALCA—migraine	1.72e-05	0.00166	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—migraine	1.67e-05	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH4—migraine	1.62e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH3—migraine	1.61e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR7—migraine	1.61e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MTHFR—migraine	1.61e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR1B—migraine	1.56e-05	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR1D—migraine	1.51e-05	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR1A—migraine	1.5e-05	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TAC1—migraine	1.48e-05	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NPS—migraine	1.48e-05	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH4—migraine	1.46e-05	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ESR1—migraine	1.46e-05	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2C—migraine	1.45e-05	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.44e-05	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH4—migraine	1.44e-05	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EDNRA—migraine	1.41e-05	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2B—migraine	1.41e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFBR2—migraine	1.39e-05	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH3—migraine	1.38e-05	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALCA—migraine	1.36e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MTHFR—migraine	1.35e-05	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PGR—migraine	1.34e-05	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PGR—migraine	1.32e-05	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR7—migraine	1.27e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH3—migraine	1.24e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LRP1—migraine	1.24e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH3—migraine	1.22e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR1—migraine	1.22e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CACNA1A—migraine	1.15e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2A—migraine	1.13e-05	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFBR2—migraine	1.09e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ESR1—migraine	1e-05	0.000964	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH4—migraine	9.5e-06	0.000914	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CACNA1A—migraine	9.32e-06	0.000897	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR1—migraine	9.26e-06	0.000891	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR1B—migraine	9.16e-06	0.000881	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—migraine	8.9e-06	0.000856	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR1A—migraine	8.82e-06	0.000848	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NPS—migraine	8.68e-06	0.000836	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PGR—migraine	8.68e-06	0.000836	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TAC1—migraine	8.68e-06	0.000836	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2C—migraine	8.52e-06	0.000819	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDNRA—migraine	8.29e-06	0.000797	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH3—migraine	8.07e-06	0.000777	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCA—migraine	7.98e-06	0.000767	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ESR1—migraine	7.9e-06	0.00076	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR7—migraine	7.46e-06	0.000718	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR1—migraine	7.02e-06	0.000676	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR2—migraine	6.42e-06	0.000618	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CACNA1A—migraine	6.15e-06	0.000592	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—migraine	5.22e-06	0.000503	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—migraine	3.79e-06	0.000365	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—migraine	3.08e-06	0.000297	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—migraine	2.03e-06	0.000196	CbGpPWpGaD
